XML 40 R31.htm IDEA: XBRL DOCUMENT v3.7.0.1
Cash and Marketable Securities (Tables)
12 Months Ended
Dec. 31, 2016
Cash and Cash Equivalents [Abstract]  
Schedule of Investment Components
The components of our investments as of December 31, 2016 are as follows (in millions):
 
Cash & Cash Equivalents
 
Restricted Cash
 
Restricted Marketable Securities
 
Total
Cash
$
40.5

 
$
60.9

 
$

 
$
101.4

Equity securities

 

 
57.7

 
57.7

Total
$
40.5

 
$
60.9


$
57.7

 
$
159.1

The components of our investments as of December 31, 2015 are as follows (in millions):
 
Cash & Cash Equivalents
 
Restricted Cash
 
Restricted Marketable Securities
 
Total
Cash
$
61.6

 
$
45.9

 
$

 
$
107.5

Equity securities

 

 
56.2

 
56.2

Total
$
61.6

 
$
45.9

 
$
56.2

 
$
163.7

Schedule of Restricted Cash
As of December 31, 2016 and 2015, Restricted cash consisted of the following (in millions):
 
As of December 31,
 
2016
 
2015
Affiliate cash
$
22.9

 
$
20.3

Self-insured captive funds
38.0

 
25.6

Total restricted cash
$
60.9

 
$
45.9

Available-for-sale Securities Cost to Fair Value Reconciliation
A summary of our restricted marketable securities as of December 31, 2015 is as follows (in millions):
 
Cost
 
Gross Unrealized Gains
 
Gross Unrealized Losses
 
Fair Value
Equity securities
$
58.3

 
$
0.3

 
$
(2.4
)
 
$
56.2

A summary of our restricted marketable securities as of December 31, 2016 is as follows (in millions):
 
Cost
 
Gross Unrealized Gains
 
Gross Unrealized Losses
 
Fair Value
Equity securities
$
59.6

 
$
0.2

 
$
(2.1
)
 
$
57.7

Investment information related to restricted marketable securities
Investing information related to our restricted marketable securities is as follows (in millions):
 
For the Year Ended December 31,
 
2016
 
2015
 
2014
Proceeds from sales of restricted available-for-sale securities
$

 
$

 
$

Proceeds from sales of nonrestricted available-for-sale securities
$

 
$
12.8

 
$
2.7

Gross realized gains
$

 
$
1.2

 
$
0.5

Gross realized losses
$

 
$

 
$
(0.1
)